% Expired Patents = 33.3

CIPO Patents = 2

EPO Patents = 1

Forward Citations = 27

Loading Chart...

6 inventors (with patents filed for the assignee):

Roberto Maj (6 out of 10 patents)

Franco Pattarino (6 out of 7 patents)

Alcide Barberis (4 out of 22 patents)

4. Emanuela Mura (4 out of 5 patents)

5. Lorenzo Leoni (2 out of 4 patents)

6. Carlo Vecchio (2 out of 2 patents)

7. Roberto Maj (1 patent)

8. Roberto Maj (0 patent)

6 patents: Sort by Forward Citations

1. 9180183 - Phospholipid drug analogs (2015-11-10),

2. 9173936 - Phospholipid drug analogs (2015-11-03),

3. 9173935 - Phospholipid drug analogs (2015-11-03),

4. 9107919 - Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration (2015-08-18),

5. 9066940 - Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration (2015-06-30),

6. 9050319 - Phospholipid drug analogs (2015-06-09),

Company Overview

Telormedix is a Swiss clinical stage biopharmaceutical company focused on developing innovative treatments for cancer patients. The company's lead product candidate, TMX-049, is currently in clinical trials for the treatment of solid tumors. Telormedix is committed to advancing the field of immuno-oncology and improving outcomes for cancer patients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#4 in Bioggio

#1,587 in Switzerland

Bioggio, Switzerland

Telormedix Sa

Forward Citations = 27

6 inventors:

Roberto Maj (6 out of 10 patents)

Franco Pattarino (6 out of 7 patents)

Alcide Barberis (4 out of 22 patents)

4. Emanuela Mura (4 out of 5 patents)

5. Lorenzo Leoni (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Telormedix Sa. Retrieved from https://idiyas.com/company/telormedix-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]